Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “NSCLC Stage IV”
Phase 3 1
- N-803ImmunityBio, Inc.NSCLC Stage IV
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.